Carol Chen

8.2k total citations · 1 hit paper
56 papers, 2.0k citations indexed

About

Carol Chen is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Carol Chen has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 13 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Carol Chen's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (9 papers). Carol Chen is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (9 papers). Carol Chen collaborates with scholars based in Canada, United States and Spain. Carol Chen's co-authors include Robert E. W. Hancock, Amir Foroushani, Geoffrey L. Winsor, Raymond Lo, Fiona S. L. Brinkman, David J. Lynn, Karin Breuer, Matthew R. Laird, Matthew C. Lorincz and Mohammad M. Karimi and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Carol Chen

51 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation

2012 858 citations Carol Chen, Robert E. W. Hancock et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol Chen Canada	16	1.1k	341	303	222	183	56	2.0k
Matthew F. Starost United States	28	1.3k 1.2×	260 0.8×	392 1.3×	308 1.4×	103 0.6×	97	2.4k
Andrew C. Nelson United States	26	656 0.6×	424 1.2×	652 2.2×	198 0.9×	82 0.4×	85	1.9k
Flavio Lejbkowicz Israel	21	1.0k 0.9×	307 0.9×	206 0.7×	214 1.0×	325 1.8×	55	2.0k
Benedict Yan Singapore	27	1.0k 0.9×	513 1.5×	105 0.3×	272 1.2×	241 1.3×	72	2.1k
Katherine J. Martin United States	30	1.4k 1.3×	395 1.2×	235 0.8×	282 1.3×	96 0.5×	66	2.7k
Abul Bashar Mir Md. Khademul Islam Bangladesh	30	1.7k 1.5×	485 1.4×	441 1.5×	517 2.3×	54 0.3×	87	2.6k
Hiroki Sato Japan	25	729 0.7×	433 1.3×	251 0.8×	349 1.6×	76 0.4×	115	1.9k
Liisa Nissinen Finland	32	1.2k 1.1×	492 1.4×	569 1.9×	683 3.1×	179 1.0×	74	2.8k
Ignacio González-Gómez United States	31	801 0.7×	171 0.5×	144 0.5×	199 0.9×	96 0.5×	91	2.6k
Joanna Wesoły Poland	27	1.0k 0.9×	520 1.5×	941 3.1×	293 1.3×	88 0.5×	67	2.2k

Countries citing papers authored by Carol Chen

Since Specialization

Citations

This map shows the geographic impact of Carol Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Chen more than expected).

Fields of papers citing papers by Carol Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Chen. The network helps show where Carol Chen may publish in the future.

Co-authorship network of co-authors of Carol Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Chen. A scholar is included among the top collaborators of Carol Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Chen. Carol Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Chin‐Yuan, et al.. (2025). Protocol for reconstituting enzymatic activities for ultra-large histone methyltransferases NSD1 and SETD2 using a baculovirus expression system. STAR Protocols. 6(3). 103963–103963. 1 indexed citations

Chen, Carol, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms. European Journal Of Haematology. 115(2). 142–152. 3 indexed citations

Chen, Carol, Eshetu G. Atenafu, Arjun Law, et al.. (2025). Conditioning Regimens for Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Graft Failure. Transplantation and Cellular Therapy. 31(10). 810–819. 1 indexed citations

Pašić, Ivan, Mats Remberger, Carol Chen, et al.. (2024). Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study. Transplantation and Cellular Therapy. 30(7). 681.e1–681.e11. 2 indexed citations

Remberger, Mats, Carol Chen, Igor Novitzky‐Basso, et al.. (2024). PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation. Blood Advances. 9(3). 660–669. 7 indexed citations

Salas, María Queralt, Eshetu G. Atenafu, Arjun Law, et al.. (2024). Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 30(5). 536.e1–536.e13. 4 indexed citations

Chen, Carol, Armin Gerbitz, Dennis Dong Hwan Kim, et al.. (2024). Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 30(5). 520.e1–520.e12. 3 indexed citations

Chen, Carol, Augusto Faria Andrade, & Nada Jabado. (2023). SMARCA4 vulnerability in H3K27M midline glioma: A silver bullet for a lethal disease. Molecular Cell. 83(2). 163–164. 3 indexed citations

Andrade, Augusto Faria, Carol Chen, & Nada Jabado. (2023). Oncohistones in brain tumors: the soil and seed. Trends in cancer. 9(5). 444–455. 11 indexed citations

10.

Salas, María Queralt, Eshetu G. Atenafu, Ivan Pašić, et al.. (2023). HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 58(11). 1237–1246. 2 indexed citations

11.

Chen, Shiyi, Carol Chen, Ivan Pašić, et al.. (2023). Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience. Annals of Hematology. 102(4). 917–926.

12.

Wibmer, Andreas G., Paul C. Dinh, Lois B. Travis, et al.. (2022). Associations of Body Fat Distribution and Cardiometabolic Risk of Testicular Cancer Survivors After Cisplatin-Based Chemotherapy. JNCI Cancer Spectrum. 6(4). 8 indexed citations

13.

Nampoothiri, Ram Vasudevan, Arjun Law, Wilson Lam, et al.. (2021). Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. Hematology/Oncology and Stem Cell Therapy. 15(1). 27–35. 5 indexed citations

14.

Salas, María Queralt, Eshetu G. Atenafu, Arjun Law, et al.. (2021). Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(5). 428.e1–428.e9. 19 indexed citations

15.

Chen, Carol, Ashot S. Harutyunyan, Xiao Chen, et al.. (2021). Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marks. Molecular Cell. 81(23). 4876–4890.e7. 29 indexed citations

16.

Novitzky‐Basso, Igor, Mats Remberger, Carol Chen, et al.. (2020). Risk factors for graft failure in allogeneic hematopoietic stem cell transplantation: a single-center study. 9(4). 37–47. 1 indexed citations

17.

Chen, Carol, et al.. (2017). H3S10ph broadly marks early-replicating domains in interphase ESCs and shows reciprocal antagonism with H3K9me2. Genome Research. 28(1). 37–51. 30 indexed citations

18.

Pena, Olga M., Nicole Afacan, Jelena Pistolic, et al.. (2013). Synthetic Cationic Peptide IDR-1018 Modulates Human Macrophage Differentiation. PLoS ONE. 8(1). e52449–e52449. 77 indexed citations

19.

Tang, Jie, Carol Chen, & Yuanli Zhao. (2011). Neurosurgery Center of Beijing Tiantan Hospital, Flagship of Neurosurgery in China. World Neurosurgery. 75(3-4). 377–382. 6 indexed citations

20.

Chen, Carol, et al.. (2010). The Chiasmal Spur. Journal of Neuro-Ophthalmology. 30(2). 157–159.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact